You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 17, 2025

Details for Patent: 10,098,863


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,098,863 protect, and when does it expire?

Patent 10,098,863 protects BAFIERTAM and is included in one NDA.

This patent has nineteen patent family members in seven countries.

Summary for Patent: 10,098,863
Title:Fumarate esters
Abstract: Described herein are pharmaceutical compositions comprising one or more fumarate esters, processes for making the same, and compositions and methods for treating multiple sclerosis subjects with the compositions. In particular, oral pharmaceutical compositions comprising fumarate esters in liquid vehicles are described. One embodiment is an oral delayed release pharmaceutical dosage form comprising a soft capsule encapsulating an immediate releasing liquid comprising one or more fumarate esters.
Inventor(s): Vaughn; Jason M. (Browns Summit, NC), Hughey; Justin R. (Asheboro, NC), Roberts; Tanesha (Greensboro, NC), Dyakonov; Tatyana (Greensboro, NC), Agnihotri; Sunil (Scarborough, ME), Fatmi; Aqeel A. (High Point, NC)
Assignee: Banner Life Sciences LLC (High Point, NC)
Application Number:15/686,352
Patent Claim Types:
see list of patent claims
Use; Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a Patent: A Detailed Guide Using United States Patent 10,098,863 as an Example

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the specifics of analyzing the scope and claims of a patent, using United States Patent 10,098,863 as a case study.

Understanding Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often a subject of debate, particularly in discussions about patent quality and the potential for overly broad patents[3].

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can correlate with other indicators of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Patent Claims: The Heart of a Patent

Patent claims define the scope of the invention and are the most critical part of a patent. They must be clear, concise, and supported by the patent's description.

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Claim Language and Scope

The language used in claims can significantly affect the patent's scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Analyzing United States Patent 10,098,863

Patent Overview

To analyze the scope and claims of United States Patent 10,098,863, one must first understand the patent's subject matter. Here is a general approach:

  1. Identify the Invention: Determine what the patent is about by reading the abstract and the detailed description.
  2. Review the Claims: Examine the independent and dependent claims to understand the scope of protection.

Step-by-Step Analysis

1. Accessing the Patent Document

Use the USPTO's Patent Public Search tool or other databases like PATENTSCOPE to access the full text of the patent[1][4].

2. Reading the Abstract and Description

The abstract provides a brief summary of the invention, while the detailed description explains the invention in full detail.

3. Analyzing the Claims

  • Independent Claims: Identify the independent claims, which define the broadest scope of the invention.
  • Dependent Claims: Review the dependent claims, which narrow down the scope further.

4. Evaluating Claim Language

Check the length and complexity of the claims. Shorter, clearer claims are generally more enforceable and less likely to be challenged[3].

Example: Claim Analysis of US Patent 10,098,863

Assuming US Patent 10,098,863 is for a technological innovation, here’s how you might analyze its claims:

  • Independent Claim 1: This claim would define the core invention without any limitations.
    • Example: "A system for [brief description of the system], comprising [key components]."
  • Dependent Claim 2: This claim would further limit the scope of Independent Claim 1.
    • Example: "The system of claim 1, wherein [additional feature or limitation]."

Understanding the Cooperative Patent Classification (CPC)

The CPC system helps in categorizing patents and can be used to find similar patents and understand the broader patent landscape. Searching the CPC database can provide insights into how the patent fits within its technological field[4].

Global Patent Landscape

Searching International Patent Offices

To understand the global implications of a patent, it is essential to search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by multiple offices for the same patent family, providing a comprehensive view of the global patent landscape[1].

Tools and Resources for Patent Analysis

USPTO Resources

  • Patent Public Search: A powerful tool for searching U.S. and international patents.
  • Global Dossier: Provides access to file histories and related applications from participating IP offices.
  • Patent and Trademark Resource Centers (PTRCs): Offers local search resources and training in patent search techniques[1].

Other Databases

  • PATENTSCOPE: Provides full-text search of international patent applications and granted patents.
  • European Patent Office (EPO) databases: Offers access to European patent databases and machine translations[4].

Legal and Policy Considerations

Enablement and Written Description

The USPTO guidelines on enablement and written description are crucial for ensuring that the patent claims are supported by the patent's description. This is particularly relevant in the context of utility applications[5].

Potential for Litigation

The scope and claims of a patent can significantly impact its enforceability and the potential for litigation. Narrower, clearer claims are generally less likely to be challenged in court[3].

Key Takeaways

  • Patent Scope: Metrics such as independent claim length and count can help measure the scope of a patent.
  • Claim Analysis: Independent and dependent claims define the patent's scope, with narrower claims often being more enforceable.
  • Global Landscape: Searching international patent databases is essential for understanding the global implications of a patent.
  • Tools and Resources: Utilize USPTO resources, such as Patent Public Search and Global Dossier, along with other international databases.

FAQs

Q: How do I access the full text of a U.S. patent?

A: You can access the full text of a U.S. patent using the USPTO's Patent Public Search tool or other databases like PATENTSCOPE[1][4].

Q: What is the difference between independent and dependent claims?

A: Independent claims define the broadest scope of the invention, while dependent claims further limit the scope of an independent claim.

Q: Why is the Cooperative Patent Classification (CPC) important?

A: The CPC helps in categorizing patents and finding similar patents, providing insights into the broader patent landscape[4].

Q: How can I determine if a patent has been granted in other countries?

A: Use international patent databases such as those provided by the EPO, JPO, and WIPO to search for patents granted in other countries[1].

Q: What are the implications of broader versus narrower patent claims?

A: Broader claims may be more likely to be challenged and have a longer examination process, while narrower claims are generally more enforceable and have a shorter examination process[3].

Sources

  1. USPTO: Search for patents - USPTO.
  2. ACUS: U.S. Patent Small Claims Court.
  3. SSRN: Patent Claims and Patent Scope.
  4. Clemson University: Research and Course Guides: Patent Searching, Advanced: Overview.
  5. Federal Register: Guidelines for Assessing Enablement in Utility Applications and ...

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,098,863

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Banner Life Sciences BAFIERTAM monomethyl fumarate CAPSULE, DELAYED RELEASE;ORAL 210296-001 Apr 28, 2020 RX Yes Yes 10,098,863 ⤷  Try for Free Y METHOD OF TREATING MULTIPLE SCLEROSIS ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,098,863

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015222880 ⤷  Try for Free
Australia 2015328676 ⤷  Try for Free
Australia 2016253548 ⤷  Try for Free
Australia 2017204505 ⤷  Try for Free
Canada 2939990 ⤷  Try for Free
Canada 2962916 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.